Stockscreener 앱 받기
31.53
1.93%
-0.62
전일 마감가:
$32.15
열려 있는:
$31.81
하루 거래량:
728.75K
Relative Volume:
0.53
시가총액:
$1.76B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-18.55
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
-3.64%
1개월 성능:
-0.47%
6개월 성능:
-44.60%
1년 성능:
-61.05%
1일 변동 폭
$31.23
$31.93
1주일 범위
$31.23
$33.28
52주 변동 폭
$27.80
$89.49
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
PRCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
31.53 | 1.80B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
125.78 | 216.61B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.01 | 141.96B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.12 | 134.80B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.66 | 123.27B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.20 | 50.45B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Aug EndMonth: What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceJuly 2025 Gainers & AI Driven Stock Movement Reports - Улправда
Transcript : PROCEPT BioRobotics Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08 - marketscreener.com
Will PROCEPT BioRobotics Corporation stock outperform value stocksMarket Risk Summary & Technical Pattern Alert System - DonanımHaber
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Procept BioRobotics price target lowered to $47 from $50 at Truist - TipRanks
Truist Financial Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price - MarketBeat
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $47 - 富途牛牛
Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating - marketscreener.com
Procept BioRobotics initiated with a buy at UBS - MSN
3 Underrated Robotics Stocks Poised for Huge Gains - Investing.com
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit - 富途牛牛
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Bought by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Initiates Coverage of PROCEPT BioRobotics (PRCT) with Buy Recommendation - Nasdaq
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Procept BioRobotics initiated with a Buy at UBS - TipRanks
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $62 - 富途牛牛
Promising Growth and Investment Opportunity for PROCEPT BioRobotics: Analyst Buy Rating - TipRanks
Frontier Capital Management Co. LLC Acquires 203,602 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth By Investing.com - Investing.com South Africa
PROCEPT BioRobotics (PRCT): Reassessing Valuation After BofA Downgrade and Slower Aquablation Growth Concerns - simplywall.st
Axa S.A. Purchases 63,519 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Next Century Growth Investors LLC Buys 62,112 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Federated Hermes Inc. Acquires 25,863 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Does PROCEPT BioRobotics (PRCT) Slower Aquablation Uptake Recast Its Long-Term Market Penetration Story? - Yahoo Finance
Does Slower Aquablation Growth at PROCEPT (PRCT) Hint At A Transition In Its Long-Term Story? - Sahm
PROCEPT BioRobotics Faces Slower Growth As BofA Lowers Rating - Finimize
PROCEPT BioRobotics’ (PRCT) “Neutral” Rating Reaffirmed at Bank of America - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap DownHere's Why - MarketBeat
PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says - marketscreener.com
Procept Biorobotics Shares Slide Amid Downgrade - TipRanks
Procept BioRobotics downgraded to neutral at BofA on slowing utilization - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Given "Neutral" Rating at Bank of America - MarketBeat
Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com Australia
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by Thematics Asset Management - MarketBeat
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Hold - MarketBeat
Wall Street analysts’ outlook for Procept BioRobotics Corp (PRCT) - setenews.com
Is PROCEPT BioRobotics Corporation stock a buy before product launchesWeekly Stock Report & Short-Term High Return Ideas - Newser
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.5%What's Next? - MarketBeat
Granite Investment Partners LLC Makes New Investment in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Mackenzie Financial Corp Buys New Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.48%
자본화:
|
볼륨(24시간):